Mwanzo1SXP • ETR
add
SCHOTT Pharma AG & Co KgaA
Bei iliyotangulia
€ 20.00
Bei za siku
€ 19.60 - € 20.20
Bei za mwaka
€ 18.50 - € 32.74
Thamani ya kampuni katika soko
2.96B EUR
Wastani wa hisa zilizouzwa
elfu 56.65
Uwiano wa bei na mapato
20.43
Mgao wa faida
0.80%
Ubadilishanaji wa msingi
ETR
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (EUR) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 256.46M | 1.13% |
Matumizi ya uendeshaji wa biashara | 35.98M | 10.22% |
Mapato halisi | 45.56M | -1.51% |
Kiwango cha faida halisi | 17.77 | -2.58% |
Mapato kwa kila hisa | 0.30 | -3.23% |
EBITDA | 79.85M | 12.55% |
Asilimia ya kodi ya mapato | 23.96% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (EUR) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 28.29M | 27.69% |
Jumla ya mali | 1.53B | 9.23% |
Jumla ya dhima | 663.12M | 5.30% |
Jumla ya hisa | 865.03M | — |
hisa zilizosalia | 151.88M | — |
Uwiano wa bei na thamani | 3.52 | — |
Faida inayotokana na mali | 9.97% | — |
Faida inayotokana mtaji | 13.15% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (EUR) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 45.56M | -1.51% |
Pesa kutokana na shughuli | 55.18M | -4.73% |
Pesa kutokana na uwekezaji | -37.89M | -56.48% |
Pesa kutokana na ufadhili | -14.41M | 52.04% |
Mabadiliko halisi ya pesa taslimu | 2.20M | -29.99% |
Mtiririko huru wa pesa | -28.83M | -170.61% |
Kuhusu
Schott Pharma is a provider of drug containment solutions and delivery systems for injectable drugs. Originally a division of glass manufacturer Schott AG, the company went public on the Frankfurt Stock Exchange in 2023. Headquartered in Mainz, Germany, the company operates in 14 countries. Wikipedia
Ilianzishwa
1 Ago 2022
Tovuti
Wafanyakazi
4,775
